Menu

Table of Contents:

Read online

G. Demolin MD

Department of Oncology, Integrated Oncology Center CHC-Liège, Liège, Belgium
former positions
Department of Oncology, Clinique Saint-Joseph, Liege, Belgium
Department of Gastro-Enterology, Clinique Saint-Joseph, Liege, Belgium

Articles

Bone lytic lesion: breast cancer metastase or sarcoidosis? A case-report

BJMO - volume 8, issue 1, march 2014

A.C. Davin MD, M-P. Graas MD, G. Demolin MD, G. Namur MD, B. Massart MD, C. Focan MD, PhD

The authors present the case of a 47 year old woman with a history of a primary breast cancer and local recurrence, who developed disseminated pulmonary lesions, supra- and infra-diaphragmatic adenopathies and a lytic lesion of the right iliac bone nine years later. The diagnosis of disseminated carcinomatosis was initially suspected but a targeted bone biopsy surprisingly revealed the presence of sarcoidosis typical lesions. In this case, none of the sophisticated imaging tools could provide an accurate differential diagnosis. Thus for such cases, an anatomo-pathological analysis is definitively mandatory in order to avoid overtreating patients without evolutive cancer.

(BELG J MED ONCOL 2014;8(1):1–7)

Read more

Haemolytic uraemic syndrome culminating in terminal renal failure after gemcitabine treatment: case report and literature survey

BJMO - volume 7, issue 2, may 2013

M-P. Graas MD, G. Demolin MD, G. Houbiers MD, P. Gomez , C. Focan MD, PhD

Summary

We report the case of a woman treated for an ovarian cancer who ultimately developed terminal renal failure in the frame of a haemolytic uraemic syndrome induced by prolonged gemcitabine therapy. This case illustrates the need of a systematic screening for haemolytic uraemic syndrome in patients receiving protracted gemcitabine for over three months.

(BELD J ONCOL MED 2013;7(2):50–52)

Read more
X